(Q38056872)

27 August 2017

title

Colorectal liver metastases: state of the art imaging (English)

1 reference

27 August 2017

3

Christine O Menias

1 reference

27 August 2017

Kathryn Jane Fowler

1

1 reference

27 August 2017

David C Linehan

series ordinal

2

1 reference

27 August 2017

publication date

1 November 2012

1 reference

Annals of Surgical Oncology

27 August 2017

published in

1 reference

27 August 2017

volume

20

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

1185-1193

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-012-2730-7

27 August 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Treatment advances in liver-limited metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Curable metastatic colorectal cancer: recommended paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Perioperative chemotherapy for resectable hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Preoperative evaluation of patients awaiting liver transplantation: comparison of multiphasic contrast-enhanced 3D magnetic resonance to helical computed tomography examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Preoperative hepatic vascular evaluation with CT and MR angiography: implications for surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Arterial therapies of colorectal cancer metastases to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Liver magnetic resonance diffusion weighted imaging: 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2730-7

10.1245/S10434-012-2730-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1014332973

0 references

1 reference